Commentary on Ezard et al.: Prescribed psychostimulant medications for methamphetamine use disorder – an urgent path forward
Year: 2025
Type: editorial
Abstract: Prescribed psychostimulant medications for methamphetamine use disorderan urgent path forward Prescribed stimulants, modeled after opioid agonist therapies, show modest benefits for individuals with severe stimulant use disorder.Higher doses of extended-release preparations appear safe and can reduce illicit stimulant use, although retention in care remains a challenge.Combining these medications with psychosocial interventions may help further, but more rigorous trials are needed to refine dosing, ensure safety and enhance real-world applications.
Source: Addiction
DOI: 10.1111/add.70058
Author: Adam Bisaga
Institution: Columbia University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4409038765